No abstract available
Keywords:
Mounjaro; Saxenda; Wegovy; Zepbound; adverse effects; dosage; drug interactions; efficacy; lactation; liraglutide; pregnancy; safety; semaglutide; tirzepatide; weight loss.
MeSH terms
-
Diabetes Mellitus, Type 2*
-
Gastric Inhibitory Polypeptide*
-
Glucagon-Like Peptide-1 Receptor
-
Humans
-
Hypoglycemic Agents
Substances
-
tirzepatide
-
Gastric Inhibitory Polypeptide
-
Hypoglycemic Agents
-
Glucagon-Like Peptide-1 Receptor